Prevalence of cardiovascular disease in uraemia and relevance of cardiovascular risk factors

被引:14
作者
Collado, S. [1 ]
Coll, E. [2 ]
Deulofeu, R. [3 ]
Guerrero, L. [3 ]
Pons, M. [4 ]
Cruzado, J. M. [5 ]
de la Torre, B. [6 ]
Vera, M. [7 ]
Azqueta, M. [8 ]
Nicolau, C. [9 ]
Cases, A. [7 ]
机构
[1] Hosp del Mar, Serv Nefrol, Barcelona, Spain
[2] Fundacio Puigvert, Serv Nefrol, Barcelona, Spain
[3] Hosp Clin Barcelona, CDB, Barcelona, Spain
[4] CETIRSA, Barcelona, Spain
[5] Inst Hemodialisis, Barcelona, Spain
[6] CD Bonanova, Barcelona, Spain
[7] Hosp Clin Barcelona, Serv Nefrol, Barcelona, Spain
[8] Hosp Clin Barcelona, Serv Cardiol, Barcelona, Spain
[9] Hosp Clin Barcelona, CDI, Barcelona, Spain
来源
NEFROLOGIA | 2010年 / 30卷 / 03期
关键词
End-stage renal disease; Cardiovascular disease; Cardiovascular risk factors; STAGE RENAL-DISEASE; CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; EVENTS; FAILURE; STRESS;
D O I
10.3265/Nefrologia.pre2010.Apr.10410
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aim: To evaluate the prevalence of cardiovascular disease (CVD) and its association with cardiovascular risk factors, as well as their control in end-stage renal disease (ESRD) patients under maintenance hemodialysis (HD). Patients and methods: A total of 265 patients with ESRD on maintenance HD from a University Hospital and 4 dialysis units were included in this multicenter and cross-sectional study that analyzed the prevalence of CVD and the possible association with classic and new cardiovascular risk factors. Usual biochemical and haemathological parameters were analyzed, as well as plasma levels of homocysteine, troponin-I, BNP, lipoprotein(a), C reactive protein, IL-6, fibrinogen, asymmetrical dimethylarginine (ADMA), advanced oxidation protein products (AOPP), malondialdehyde, adiponectin, osteoprotegerin, and fetuin. In a subset of patients an echocardiography and carotid artery Doppler echography were also performed. Results: The prevalence of CVD was 52.8%. Factors positively associated with prevalent CVD were age, BMI, left ventricular hypertrophy, hypertension, dyslipidemia and diabetes mellitus, dialysis vintage, Charlson's comorbility index, levels of fibrinogen, osteoprotegerin, BNP and CRP, as well as carotid intima-media thickness, left ventricular mass and pulse pressure. Factors negatively associated with prevalent CVD were: previous renal transplant ejection fraction or levels of LDL-c and phosphorous. In the multivariate analysis dyslipidemia, left ventricular hypertrophy, age and LDL-c (negatively) were associated with CVD. Conclusions: In HD patients the prevalence of CVD is high and is associated with the presence of cardiovascular risk factors and subclinical CVD.
引用
收藏
页码:342 / 348
页数:7
相关论文
共 24 条
[1]  
Becker BN, 1997, J AM SOC NEPHROL, V8, P475
[2]   Prognostic significance of arterial stiffness measurements in end-stage renal disease patients [J].
Blacher, J ;
Safar, ME ;
Pannier, B ;
Guerin, AP ;
Marchais, SJ ;
London, GM .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2002, 11 (06) :629-634
[3]  
Descamps-Latscha A, 2005, AM J KIDNEY DIS, V45, P39, DOI 10.1053/j.ajkd.2004.09.011
[4]   The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease [J].
Ezekowitz, J ;
McAlister, FA ;
Humphries, KH ;
Norris, CM ;
Tonelli, M ;
Ghali, WA ;
Knudtson, ML .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (08) :1587-1592
[5]   Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis [J].
Fellstroem, Bengt C. ;
Jardine, Alan G. ;
Schmieder, Roland E. ;
Holdaas, Hallvard ;
Bannister, Kym ;
Beutler, Jaap ;
Chae, Dong-Wan ;
Chevaile, Alejandro ;
Cobbe, Stuart M. ;
Groenhagen-Riska, Carola ;
De Lima, Jose J. ;
Lins, Robert ;
Mayer, Gert ;
McMahon, Alan W. ;
Parving, Hans-Henrik ;
Remuzzi, Giuseppe ;
Samuelsson, Ola ;
Sonkodi, Sandor ;
Sueleymanlar, Gultekin ;
Tsakiris, Dimitrios ;
Tesar, Vladimir ;
Todorov, Vasil ;
Wiecek, Andrzej ;
Wuethrich, Rudolf P. ;
Gottlow, Mattis ;
Johnsson, Eva ;
Zannad, Faiez .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (14) :1395-1407
[6]  
Joki N., 1999, Nephrology Dialysis Transplantation, V14, pA171
[7]   Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? [J].
Levey, AS ;
Beto, JA ;
Coronado, BE ;
Eknoyan, G ;
Foley, RN ;
Kasiske, BL ;
Klag, MJ ;
Mailloux, LU ;
Manske, CL ;
Meyer, KB ;
Parfrey, PS ;
Pfeffer, MA ;
Wenger, NK ;
Wilson, PWF ;
Wright, JT .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) :853-906
[8]   ACCELERATED ATHEROSCLEROSIS IN PROLONGED MAINTENANCE HEMODIALYSIS [J].
LINDNER, A ;
CHARRA, B ;
SHERRARD, DJ ;
SCRIBNER, BH .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (13) :697-701
[9]   Cardiac and arterial interactions in end-stage renal disease [J].
London, GM ;
Guerin, AP ;
Marchais, SJ ;
Pannier, B ;
Safar, ME ;
Day, M ;
Metivier, F .
KIDNEY INTERNATIONAL, 1996, 50 (02) :600-608
[10]   2007 ESH-ESC practice guidelines for the management of arterial hypertension - ESH-ESC task force on the management of arterial hypertension [J].
Mancia, Giuseppe ;
De Backer, Guy ;
Dominiczak, Anna ;
Cifkova, Renata ;
Fagarde, Robert ;
Germanof, Giuseppe ;
Grassi, Guido ;
Heagertyh, Anthony M. ;
Kjeldsen, Sverre E. ;
Laurenti, Stephanie ;
Narkiewicz, Krzysztof ;
Ruilopel, Luis ;
Rynkiewicz, Andrzej ;
Schmiedern, Roland E. ;
Boudiero, Harry A. J. Struijker ;
Zanchetti, Alberto .
JOURNAL OF HYPERTENSION, 2007, 25 (09) :1751-1762